Picture of Kissei Pharmaceutical logo

4547 — Kissei Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Kissei Pharm -2020/21 group results

May 11 (Reuters)- 
          Kissei Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           69.04           63.23          63.50        31.50    
               (+9.2 pct)      (-12.5 pct)    (-8.0 pct)    (-2.4 pct) 
  Operating        1.51            1.86        loss 2.60    loss 1.80  
               (-19.0 pct)     (-70.1 pct)                             
  Recurring        3.48            2.43        loss 1.30    loss 1.10  
               (+43.1 pct)     (-66.1 pct)                             
  Net
  Net              5.29            2.82           3.30         3.80    
               (+87.6 pct)     (-48.6 pct)    (-37.6 pct)  (-13.6 pct) 
  EPS          113.25 yen       60.31 yen      71.56 yen    82.40 yen  
  Ann Div       54.00 yen       52.00 yen      56.00 yen               
  -Q2 Div       27.00 yen       26.00 yen      28.00 yen               
  -Q4 Div       27.00 yen       26.00 yen      28.00 yen               
  
  NOTE - Kissei Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T

Recent news on Kissei Pharmaceutical

See all news